Abstract:Background: Few studies have directly investigated the differential expression of microRNAs (miRNAs) in head and neck squamous cell carcinoma (HNSCC) with low, medium, and high tobacco exposure. The purpose of this study is to screen the differentially expressed miRNAs and to investigate their clinical significance and potential biological mechanisms in the three groups of HNSCC.Methods: The datasets of HNSCC were obtained from The Cancer Genome Atlas (TCGA). The edgeR package was used to determine differentially expressed miRNAs and genes among the three groups of HNSCC. Statistical methods were applied to assess the clinical significance of miRNA and its correlation with genes. The correlation between gene expression and clinical characteristics was analyzed using weighted gene co-expression network analysis (WGCNA). Three online databases were used to predict the target genes of miRNAs. More importantly, qRT-PCR was employed to verify the differential expression of miRNAs and genes in our patients.Results: 32 differentially expressed miRNAs and 1,820 differentially expressed genes were found among the three groups of HNSCC. Patients with high expression of hsa-miR-499a had lower overall survival than the ones with low expression in high-tobacco exposed HNSCC. Cox regression analysis found that high expression of hsa-miR-499a and female were independent risk factors for prognosis in high-tobacco exposed HNSCC. Chi-square test found that hsa-miR-499a was associated with N stage in high-tobacco exposed HNSCC. WGCNA identified four gene modules associated with N stage in high-tobacco exposed HNSCC. Then three online databases were used to predict potential target genes for hsa-miR-499a, which were AEBP2 and ZNRF1. Pearson correlation analysis showed that hsa-miR-499a was negatively correlated with AEBP2 and ZNRF1. qRT-PCR supported bioinformatic results that hsa-miR-499a, AEBP2, and ZNRF1 were differentially expressed among the three groups of HNSCC in our patients.Conclusion: 32 differentially expressed miRNAs and 1,820 differentially expressed genes were successfully identified in HNSCC with low, medium, and high tobacco exposure. The patients with high expression of hsa-miR-499a had poor prognoses compared with patients with low expression in high-tobacco exposed HNSCC. Hsa-miR-499a was associated with N stage in high-tobacco exposed HNSCC. AEBP2 and ZNRF1 were the potential target genes of hsa-miR-499a.

The clinical significance and biological mechanisms of miR-499a in high-tobacco exposed head and neck squamous cell carcinoma

1156PThe clinical significance and biological mechanisms of miR-499a in high-tobacco exposed head and neck squamous cell carcinoma

The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis

Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma

Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis

Analysis of Genetic Variants and the Cerna Network of Mir-9 in Non-Small Cell Lung Cancer

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma

A HPV16-related prognostic indicator for head and neck squamous cell carcinoma

Integrated Analysis Of Deregulation Microrna Expression In Head And Neck Squamous Cell Carcinoma

Bioinformatics Analysis of the Expression and Role of Microrna-221-3p in the Head and Neck Squamous Cell Carcinoma

A Comprehensive Investigation Using Meta-Analysis and Bioinformatics on Mir-34A-5p Expression and Its Potential Role in Head and Neck Squamous Cell Carcinoma.

Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection

MicroRNA-101 Polymorphisms and Risk of Head and Neck Squamous Cell Carcinoma in a Chinese Population

The Suppressive Role of Mir-542-5p in NSCLC: the Evidence from Clinical Data and in Vivo Validation Using a Chick Chorioallantoic Membrane Model

Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma

MicroRNA-204-5p is a Tumor Suppressor and Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma.

Overexpression of Mirna 4451 is Associated with a Poor Survival of Patients with Hypopharyngeal Cancer after Surgery with Postoperative Radiotherapy.

MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer.

[Relationships Between Microrna Expressions and Prognosis in Patients with Tongue Squamous Cell Carcinoma and the Mechanisms Microrna Regulating Tongue Squamous Cell Carcinoma Biological Behavior].

Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer